China Merchants Securities International: Initiates Coverage on Harbour BioMed (02142.HK) with "Overweight" Rating, Target Price HK$28

Zhitong Finance APP has learned that China Merchants Securities International issued a research report, initiating coverage on Harbour BioMed (02142.HK) with an "Overweight" rating and a target price of HK$28. The bank estimates the company's valuation at approximately US$3.1 billion, or HK$24.3 billion, using a risk-adjusted net present value (rNPV) calculation.